Metabolic syndrome Trials in Paris, France
Conditions / Metabolic syndrome / Paris, France
Metabolic syndrome has been the subject of sustained clinical investigation across multiple research sites.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04407780 | Cardio-Oncology Registry | RECRUITING | — |
| NCT00508157 | A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome | TERMINATED | PHASE4 |
| NCT03692806 | Efficacy of STABLOR® on Visceral Fat Mass Reduction in Patients With Metabolic Syndrome | COMPLETED | NA |
| NCT04226014 | Observational Cohort of Pancreatic Echo-endoscopy | COMPLETED | — |
| NCT02898142 | Intestines and Liver Contribution to Fasting Postprandial Hypertriglyceridemia | COMPLETED | NA |
| NCT01755104 | Effect of Stablor on Visceral Fat Loss in Patients With a Metabolic Syndrome | COMPLETED | NA |
| NCT05832190 | Correcting GUT MicrobioTa by Combined Supplementation of FibERs and BIotiN to Improve Microbiome and Optimize Bariatric Surgery Outcomes | TERMINATED | NA |
| NCT00299325 | VIsceral Fat Reduction Assessed by CT-scan On RImonabAnt | COMPLETED | PHASE3 |
| NCT01566188 | Vascular Impact of Omega-3 in Metabolic Syndrome | COMPLETED | — |
| NCT05651724 | Global Research Initiative for Patients Screening on MASH | RECRUITING | — |